| Clinical data | |
|---|---|
| ATC code | None |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | 117946-91-5 |
| PubChem (CID) | 122162 |
| ChemSpider | 108959 |
| ChEBI |
CHEBI:131788 |
| Chemical and physical data | |
| Formula | C19H20N2O |
| Molar mass | 292.375 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
Luzindole (N-0774), (N-acetyl-2-benzyltryptamine), is a drug used in scientific research to study the role of melatonin in the body. Luzindole acts as a selective melatonin receptor antagonist, with approximately 11- to 25-fold greater affinity for the MT2 over the MT1 receptor. In animal studies, it has been observed to disrupt the circadian rhythm as well as produce antidepressant effects.